Exagen Inc (XGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Exagen Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $33 | $24 | $27 | $16.34 | 65.24% |
The Trend in the Analyst Price Target
Over the past 66 days, XGN's average price target has gone up $3.25.
Over the past 287 days, XGN's average upside potential has been 50.23%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-06-09 | 2 | 20 | 17 | 18.50 | 12.64 | 46.36% |
| 2020-08-12 | 2 | 20 | 17 | 18.50 | 14.66 | 26.19% |
| 2020-10-06 | 3 | 20 | 17 | 18.33 | 12.37 | 48.18% |
| 2020-11-11 | 4 | 32 | 20 | 23.75 | 15.70 | 51.27% |
| 2020-11-28 | 4 | 32 | 20 | 23.75 | 14.75 | 61.02% |
| 2020-12-04 | 4 | 32 | 20 | 23.75 | 14.85 | 59.93% |
| 2021-01-16 | 4 | 32 | 20 | 23.75 | 15.35 | 54.72% |
| 2021-01-23 | 4 | 32 | 21 | 24.25 | 16.06 | 51% |
| 2021-01-30 | 4 | 32 | 21 | 24.25 | 15.70 | 54.46% |
| 2021-02-01 | 4 | 32 | 21 | 24.25 | 15.73 | 54.16% |
| 2021-03-20 | 4 | 33 | 24 | 27.00 | 20.00 | 35% |
| 2021-03-23 | 4 | 33 | 24 | 27.00 | 16.82 | 60.52% |
XGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.3 | 2 | 3 | 0 | 0 | 0 | 5 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XGN as an investment opportunity.
- Exagen Inc's upside potential (average analyst target price relative to current price) is greater than 81.16% of all US stocks.
- Exagen Inc's variance in analysts' estimates is lower than 31.94% of Healthcare stocks.
- Exagen Inc's average analyst price target is greater than 65.32% of stocks in the small market cap category.
- Exagen Inc's number of analysts covering the stock is greater than 36.03% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to Exagen Inc are DMTK, INNV and RDNT.
Make investment decisions regarding XGN using the data that counts. Try POWR Ratings for free.